跳至主要内容
临床试验/IRCT201201028323N5
IRCT201201028323N5已完成未知

Comparison of cinnarizine and topiramate in migraine prophylaxis

Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services0 个研究点目标入组 126 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • more than 4 and less than 10 attacks monthly ; interval between attacks more than 48 hours ; age at the onset of headache less than 50 years ; age 18-65 years ; not being pregnant or breast feeding ; discontinuation of other prophylactic drugs one month prior to the study
  • Exclusion criteria: non-migraine headaches ; overuse of medications in migraine attacks (consumption of NSAID, Ergots or Triptans more than 8 days a month) ; substance and alcohol abuse ; illiteracy of patients and their family (unable to fill diaries)

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services

相似试验